Top

Orthofix Q1 sales beat the Street, EPS narrowly misses

May 5, 2017

Orthofix (NSDQ:OFIX) shares have stayed steady in after hours trading today after the medical device maker topped sales expectations but narrowly missed EPS consensus with its 1st quarter earnings results.

The Lewisville, Texas-based company posted losses of $2.7 million, or 15¢ per share, on sales of $102.7 million for the 3 months ended March 31, seeing the bottom-line swing into the red while sales grew 4.1% compared with the same period last year.

After adjusting to exclude 1-time items, earnings per share were 27¢, just below the 29¢ consensus on The Street, where analysts were expecting to see sales of $97.2 million.

Read More on Mass Device